Business

Contract Award with New UK Client

Contract Award with New UK Client.

articlePhysiomics PlcMay 9, 20254/company/physiomics-plc/news/contract-award-with-new-uk-client
Contract Award with New UK Client

About this update from Physiomics Plc

[{"type":"text","content":"\n\n9 May 2025\n \nPhysiomics plc\n(\"Physiomics\" or the \"Company\")\n \n Contract Award with New UK Client\n \nPhysiomics plc (AIM: PYC), a leading mathematical modelling, data science and biostatistics company supporting the development of new therapeutics and personalised medicine solutions, is pleased to announce a contract award with a new UK client.\nThe project will involve the application of population Pharmacokinetic (PK) modelling techniques using Phase 1 data to inform the Phase 2 study of a small molecule designed to treat rheumatoid arthritis. The project, valued at £67,500, is expected to complete within the next three months and will be the Company's first rheumatoid arthritis project as well as one of the later development stage projects delivered to date.\nThe Company has also put in place a Master Service Agreement with the client to define and agree broad commercial terms in relation to envisaged further potential projects in the future.\n \nDr Peter Sargent, CEO of Physiomics, commented:\n\"We're delighted to have been selected to support the clinical development of this important programme. This contract award not only represents a new client relationship - the third new client in two months - but also is a reflection of our strategy to broaden our services into new therapeutic areas, being our first project in rheumatoid arthritis. In addition, this project is a great opportunity for us to demonstrate our capabilities in supporting programmes at a more advanced stage of development and is well suited to our expertise. We look forward to contributing meaningful insights that can help accelerate and optimise this molecules progress through the clinic.\"\n  \nFor more information about Physiomics and its services, please visit www.physiomics.co.uk.\n \nEnquiries:\n \nPhysiomics plc\nDr Peter Sargent, CEO\n+44 (0)1235 841575\n \nHybridan LLP (Broker)\nClaire Louise Noyce\n+44 (0) 203 764 2341\n \nStrand Hanson Ltd (NOMAD)\nJames Dance & James Bellman\n+44 (0)20 7409 3494\n \n \nNotes to Editor\n \nAbout Physiomics\n \nPhysiomics plc combines expertise across Modelling & Simulation, Biostatistics, Data Science and Bioinformatics, together with deep biology expertise, to help biotech and pharma companies streamline their drug dev...

More updates from Physiomics Plc